ANI PHARMACEUTICALS INC

ANIPReported to SECin USCIK 0001023024Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent Form 4 lines at this company, out of 15. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5 of 15
Form 4 lines at ANI PHARMACEUTICALS INC, most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
CAREY STEPHEN P.SVP & CFOOpen-market sell$208,0502,850 sharesSep 30, 2026CAREY STEPHEN P.SVP & CFO$208,050Sell · Sep 30Open-market sell2,850Sep 30, 2026
Lalwani NikhilPRESIDENT & CEOOpen-market sell$383,4005,400 sharesSep 16, 2026Lalwani NikhilPRESIDENT & CEO$383,400Sell · Sep 16Open-market sell5,400Sep 16, 2026
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.Open-market sell$35,395500 sharesSep 14, 2026Cook MeredithSR. VP, GENERAL COUNSEL & SEC.$35,395Sell · Sep 14Open-market sell500Sep 14, 2026
Thoma Jeanne—Open-market sell$71,5301,000 sharesSep 14, 2026Thoma Jeanne$71,530Sell · Sep 14Open-market sell1,000Sep 14, 2026
CAREY STEPHEN P.SVP & CFOOpen-market sell$207,4802,850 sharesSep 1, 2026CAREY STEPHEN P.SVP & CFO$207,480Sell · Sep 1Open-market sell2,850Sep 1, 2026